Substance Use Disorders: Clinical Application | October 5, 2023
Date of Presentation: October 5, 2023
Type: Past Presentation Training
Audience: Clinical
Program: Ending the Epidemics in Indian Country ECHO Program
Keywords: #fentanyl #harm reduction #medications for opioid use disorder #methamphetamine #MOUD #risk reduction #Screening #substance use disorder #SUD #SUD treatment
In this series of presentations, Dr. Jessica Gregg, and Dr. Jonathan Robbins, provide a comprehensive overview of Substance Use Disorders, including Medications for Opioid Use Disorder, Methamphetamine Use Disorder, the rise of fentanyl, and share ways to effectively integrate evidence-based clinical strategies into primary care.
Recording:
Presented by:
Jonathan Robbins | Jessica Gregg
Jonathan Leserman Robbins, MD, MS, is a general internist and primary care doctor at Oregon Health & Science University in Portland, OR. He splits his time between outpatient primary care, the inpatient addiction consult service, and a pain and addiction consult clinic. He is an active educator and participates in several ECHOs on pain and addiction.
Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for Fora Health in Portland, Oregon.
Resources Provided:
Date added: June 1, 2023